Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 113

Similar articles for PubMed (Select 16225879)

1.

Promoter haplotype of a new ABCA1 mutant influences expression of familial hypoalphalipoproteinemia.

Slatter TL, Williams MJ, Frikke-Schmidt R, Tybjaerg-Hansen A, Morison IM, McCormick SP.

Atherosclerosis. 2006 Aug;187(2):393-400. Epub 2005 Oct 12.

PMID:
16225879
2.

ABCA1 and Inflammation: From Animal Models to Humans.

Bi X, Vitali C, Cuchel M.

Arterioscler Thromb Vasc Biol. 2015 Jul;35(7):1551-3. doi: 10.1161/ATVBAHA.115.305547. No abstract available.

PMID:
26109737
3.

Genetic variants in ABCA1 promoter affect transcription activity and plasma HDL level in pigs.

Dang XY, Chu WW, Shi HC, Yu SG, Han HY, Gu SH, Chen J.

Gene. 2015 Jan 25;555(2):414-20. doi: 10.1016/j.gene.2014.11.041. Epub 2014 Nov 21.

PMID:
25445391
4.

Negative results in screening for possible new sequence variations on ATP-binding cassette transporter A1 gene in Turkish adults with metabolic syndrome.

Çoban N, Onat A, Geyik F, Erginel Ünaltuna N.

Turk Kardiyol Dern Ars. 2014 Sep;42(6):524-30. doi: 10.5543/tkda.2014.64369.

5.

Loss-of-function mutations in ABCA1 and enhanced β-cell secretory capacity in young adults.

Rickels MR, Goeser ES, Fuller C, Lord C, Bowler AM, Doliba NM, Hegele RA, Cuchel M.

Diabetes. 2015 Jan;64(1):193-9. doi: 10.2337/db14-0436. Epub 2014 Aug 14.

6.

Early senescence in heterozygous ABCA1 mutation skin fibroblasts: a gene dosage effect beyond HDL deficiency?

Puntoni M, Bigazzi F, Sabatino L, Sbrana F, Musio A, Dal Pino B, Ragusa A, Corsano E, Sampietro T.

Biochem Biophys Res Commun. 2014 May 2;447(2):231-6. doi: 10.1016/j.bbrc.2014.03.090. Epub 2014 Mar 26.

PMID:
24680682
7.

Differential phospholipid substrates and directional transport by ATP-binding cassette proteins ABCA1, ABCA7, and ABCA4 and disease-causing mutants.

Quazi F, Molday RS.

J Biol Chem. 2013 Nov 29;288(48):34414-26. doi: 10.1074/jbc.M113.508812. Epub 2013 Oct 4.

8.

Plasma amyloid-β in patients with Tangier disease.

Shahim P, Bochem AE, Mattsson N, Lautner R, Blennow K, Hovingh GK, Motazacker MM, Zetterberg H.

J Alzheimers Dis. 2013;35(2):307-12. doi: 10.3233/JAD-122425.

PMID:
23388172
9.

A novel mutation in the ABCA1 gene causing an atypical phenotype of Tangier disease.

Negi SI, Brautbar A, Virani SS, Anand A, Polisecki E, Asztalos BF, Ballantyne CM, Schaefer EJ, Jones PH.

J Clin Lipidol. 2013 Jan-Feb;7(1):82-7. doi: 10.1016/j.jacl.2012.09.004. Epub 2012 Sep 29. Erratum in: J Clin Lipidol. 2013 Jul-Aug;7(4):385.

PMID:
23351586
10.

Novel mutations of ABCA1 transporter in patients with Tangier disease and familial HDL deficiency.

Fasano T, Zanoni P, Rabacchi C, Pisciotta L, Favari E, Adorni MP, Deegan PB, Park A, Hlaing T, Feher MD, Jones B, Uzak AS, Kardas F, Dardis A, Sechi A, Bembi B, Minuz P, Bertolini S, Bernini F, Calandra S.

Mol Genet Metab. 2012 Nov;107(3):534-41. doi: 10.1016/j.ymgme.2012.08.005. Epub 2012 Aug 18.

PMID:
22959828
11.

Tangier disease: epidemiology, pathophysiology, and management.

Puntoni M, Sbrana F, Bigazzi F, Sampietro T.

Am J Cardiovasc Drugs. 2012 Oct 1;12(5):303-11. doi: 10.2165/11634140-000000000-00000.

PMID:
22913675
12.

ABCA1 gene promoter DNA methylation is associated with HDL particle profile and coronary artery disease in familial hypercholesterolemia.

Guay SP, Brisson D, Munger J, Lamarche B, Gaudet D, Bouchard L.

Epigenetics. 2012 May;7(5):464-72. doi: 10.4161/epi.19633. Epub 2012 May 1.

PMID:
22419126
13.

[Association between -14 bp and ZNF polymorphisms of ABCA1 gene promoter and high density lipoprotein cholesterol level and cardiovascular disease].

Cheng AJ, Mao YM, Cui RZ.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2012 Feb;29(1):56-9. doi: 10.3760/cma.j.issn.1003-9406.2012.01.014. Chinese.

PMID:
22311493
14.

Hepatic ABCA1 and VLDL triglyceride production.

Liu M, Chung S, Shelness GS, Parks JS.

Biochim Biophys Acta. 2012 May;1821(5):770-7. doi: 10.1016/j.bbalip.2011.09.020. Epub 2011 Oct 6. Review.

15.

Increased risk of coronary artery disease in Caucasians with extremely low HDL cholesterol due to mutations in ABCA1, APOA1, and LCAT.

Tietjen I, Hovingh GK, Singaraja R, Radomski C, McEwen J, Chan E, Mattice M, Legendre A, Kastelein JJ, Hayden MR.

Biochim Biophys Acta. 2012 Mar;1821(3):416-24. doi: 10.1016/j.bbalip.2011.08.006. Epub 2011 Aug 19.

PMID:
21875686
16.

ABCA1 impacts athero-thrombotic risk and 10-year survival in a contemporary secondary prevention setting.

Regieli JJ, Doevendans PA, Grobbee DE, Zwinderman AH, van der Graaf Y, Kastelein JJ, Jukema JW.

Atherosclerosis. 2011 Oct;218(2):457-63. doi: 10.1016/j.atherosclerosis.2011.07.008. Epub 2011 Jul 20.

17.

Homology modeling and functional testing of an ABCA1 mutation causing Tangier disease.

Suetani RJ, Sorrenson B, Tyndall JD, Williams MJ, McCormick SP.

Atherosclerosis. 2011 Oct;218(2):404-10. doi: 10.1016/j.atherosclerosis.2011.06.019. Epub 2011 Jun 29.

PMID:
21763656
18.

Genetic variation in ABCA1 and risk of cardiovascular disease.

Frikke-Schmidt R.

Atherosclerosis. 2011 Oct;218(2):281-2. doi: 10.1016/j.atherosclerosis.2011.04.010. Epub 2011 Apr 20. No abstract available.

PMID:
21601208
19.

An ABCA1 truncation shows no dominant negative effect in a familial hypoalphalipoproteinemia pedigree with three ABCA1 mutations.

Sorrenson B, Suetani RJ, Bickley VM, George PM, Williams MJ, Scott RS, McCormick SP.

Biochem Biophys Res Commun. 2011 Jun 10;409(3):400-5. doi: 10.1016/j.bbrc.2011.05.006. Epub 2011 May 7.

PMID:
21575609
20.

Associations between common genetic polymorphisms in the liver X receptor alpha and its target genes with the serum HDL-cholesterol concentration in adolescents of the HELENA Study.

Legry V, Bokor S, Beghin L, Galfo M, Gonzalez-Gross M, Molnar D, Moreno LA, Amouyel P, Dallongeville J, Meirhaeghe A; HELENA Study Group.

Atherosclerosis. 2011 May;216(1):166-9. doi: 10.1016/j.atherosclerosis.2011.01.031. Epub 2011 Jan 26.

PMID:
21316679
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk